Geneticure is a precision medicine company with operations in Arizona and Minnesota. Its patented genetic tests help physicians predict patient response to hypertension treatments, including medication selection and renal denervation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/21/26 | $1,000,000 |
Xcellerant Ventures![]() | undisclosed |